• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性卟啉病——神经学视角。

Acute porphyrias - A neurological perspective.

机构信息

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology, Berlin, Germany.

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, NeuroCure Clinical Research Center, Berlin, Germany.

出版信息

Brain Behav. 2021 Nov;11(11):e2389. doi: 10.1002/brb3.2389. Epub 2021 Oct 17.

DOI:10.1002/brb3.2389
PMID:34661997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8613433/
Abstract

Acute hepatic porphyrias (AHP) can cause severe neurological symptoms involving the central, autonomic, and peripheral nervous system. Due to their relative rarity and their chameleon-like presentation, delayed diagnosis and misdiagnosis are common. AHPs are genetically inherited disorders that result from heme biosynthesis enzyme deficiencies and comprise four forms: acute intermittent porphyria (AIP), variegate porphyria (VP), hereditary coproporphyria (HCP), and ALA-dehydratase porphyria (ALADP). Depending on the clinical presentation, the main differential diagnoses are Guillain-Barré syndrome and autoimmune encephalitis. Red flags that could raise the suspicion of acute porphyria are neurological symptoms starting after severe (abdominal) pain, in association with reddish urine, hyponatremia or photodermatitis, and the presence of encephalopathy and/or axonal neuropathy. We highlight the diagnostic difficulties by presenting three cases from our neurological intensive care unit and give a comprehensive overview about the diagnostic findings in imaging, electrophysiology, and neuropathology.

摘要

急性肝性卟啉症(AHP)可引起涉及中枢、自主和周围神经系统的严重神经症状。由于其相对罕见和表现形式多样,诊断延迟和误诊很常见。AHP 是遗传性疾病,由血红素生物合成酶缺乏引起,包括四种形式:急性间歇性卟啉症(AIP)、变异性卟啉症(VP)、遗传性粪卟啉症(HCP)和 ALA-脱水酶卟啉症(ALADP)。根据临床表现,主要的鉴别诊断是吉兰-巴雷综合征和自身免疫性脑炎。可能提示急性卟啉症的危险信号是严重(腹部)疼痛后出现神经症状,伴有红色尿液、低钠血症或光皮炎,以及脑病和/或轴索性神经病。我们通过介绍来自神经重症监护病房的三个病例,突出了诊断的困难,并对影像学、电生理学和神经病理学方面的诊断结果进行了全面概述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc2/8613433/27825744a7dc/BRB3-11-e2389-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc2/8613433/9101c1c6fd3a/BRB3-11-e2389-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc2/8613433/bb25a03f0247/BRB3-11-e2389-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc2/8613433/618f0649d81c/BRB3-11-e2389-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc2/8613433/27825744a7dc/BRB3-11-e2389-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc2/8613433/9101c1c6fd3a/BRB3-11-e2389-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc2/8613433/bb25a03f0247/BRB3-11-e2389-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc2/8613433/618f0649d81c/BRB3-11-e2389-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc2/8613433/27825744a7dc/BRB3-11-e2389-g002.jpg

相似文献

1
Acute porphyrias - A neurological perspective.急性卟啉病——神经学视角。
Brain Behav. 2021 Nov;11(11):e2389. doi: 10.1002/brb3.2389. Epub 2021 Oct 17.
2
[Porphyrias-what is verified?].[卟啉病——已证实的是什么?]
Internist (Berl). 2018 Dec;59(12):1239-1248. doi: 10.1007/s00108-018-0509-z.
3
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.AGA 临床实践更新:急性肝性血卟啉症的诊断和管理:专家综述。
Gastroenterology. 2023 Mar;164(3):484-491. doi: 10.1053/j.gastro.2022.11.034. Epub 2023 Jan 13.
4
Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).急性肝性卟啉症(AHPs)的发病机制和临床特征。
Mol Genet Metab. 2019 Nov;128(3):213-218. doi: 10.1016/j.ymgme.2019.03.002. Epub 2019 Mar 6.
5
Neurovisceral porphyrias: what a hematologist needs to know.神经内脏卟啉病:血液科医生需要了解的内容。
Hematology Am Soc Hematol Educ Program. 2005:24-30. doi: 10.1182/asheducation-2005.1.24.
6
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.急性肝卟啉症的诊断和治疗挑战:从罕见的儿科发病到创新治疗和前景。
Orphanet J Rare Dis. 2022 Apr 7;17(1):160. doi: 10.1186/s13023-022-02314-9.
7
Human hereditary hepatic porphyrias.人类遗传性肝卟啉症。
Clin Chim Acta. 2002 Nov;325(1-2):17-37. doi: 10.1016/s0009-8981(02)00276-0.
8
Acute Hepatic Porphyrias: "Purple Flags"-Clinical Features That Should Prompt Specific Diagnostic Testing.急性肝性血卟啉症:“紫色警报”——提示特定诊断检测的临床特征。
Am J Med Sci. 2022 Jan;363(1):1-10. doi: 10.1016/j.amjms.2021.09.009. Epub 2021 Oct 2.
9
Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations.急性肝卟啉症:鉴定 46 羟甲基胆素合酶、11 粪卟啉原氧化酶和 20 原卟啉原氧化酶的 46 种新突变。
Mol Genet Metab. 2019 Nov;128(3):352-357. doi: 10.1016/j.ymgme.2018.10.008. Epub 2018 Oct 26.
10
[Porphyrias].[卟啉病]
Internist (Berl). 2010 Dec;51(12):1525-33; quiz 1534. doi: 10.1007/s00108-010-2751-x.

引用本文的文献

1
Brazilian Academy of Neurology recommendations for diagnosis, management, and treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).巴西神经病学学会关于慢性炎症性脱髓鞘性多发性神经根神经病(CIDP)的诊断、管理和治疗的建议。
Arq Neuropsiquiatr. 2025 Jul;83(7):1-19. doi: 10.1055/s-0045-1809884. Epub 2025 Jul 28.
2
Features of Undiagnosed Abdominal Pain and Diagnostic Status of Acute Hepatic Porphyria in Japan: A Retrospective Study.日本未确诊腹痛的特征及急性肝卟啉病的诊断状况:一项回顾性研究
Int J Med Sci. 2025 Jun 20;22(12):3014-3021. doi: 10.7150/ijms.107826. eCollection 2025.
3
Clinical Features and Outcomes of Acute Intermittent Porphyria Presenting With Acute Quadriparesis: A Case Series and Follow-Up Study.

本文引用的文献

1
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.急性间歇性卟啉症的 RNAi 治疗药物 Givosiran 的 3 期临床试验。
N Engl J Med. 2020 Jun 11;382(24):2289-2301. doi: 10.1056/NEJMoa1913147.
2
Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran.领导性 RNA 干扰疗法 2 部分:沉默 δ-氨基乙酰丙酸合酶 1,重点介绍吉维司他。
Mol Diagn Ther. 2020 Feb;24(1):61-68. doi: 10.1007/s40291-019-00438-6.
3
Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction.
以急性四肢瘫为表现的急性间歇性卟啉病的临床特征及预后:病例系列与随访研究
Eur J Neurol. 2025 Jun;32(6):e70260. doi: 10.1111/ene.70260.
4
Diagnostic and Therapeutic Challenges in an Acute Variegate Porphyric Crisis Complicated by Anuric Renal Failure and Multiorgan Dysfunction: A Case Report.急性混合型卟啉病危象合并无尿性肾衰竭和多器官功能障碍的诊断与治疗挑战:一例报告
Am J Case Rep. 2025 Apr 26;26:e946969. doi: 10.12659/AJCR.946969.
5
Acute Hepatic Porphyria Presenting as Guillain-Barré Syndrome: Importance of Early Recognition and Screening.表现为吉兰-巴雷综合征的急性肝卟啉症:早期识别和筛查的重要性
Neurohospitalist. 2025 Apr 1:19418744251331651. doi: 10.1177/19418744251331651.
6
Porphyria presenting as posterior reversible encephalopathy syndrome.表现为后部可逆性脑病综合征的卟啉病
Acta Neurol Belg. 2025 Mar 28. doi: 10.1007/s13760-025-02773-4.
7
Practical Recommendations in the Treatment of Acute and Chronic Life-Threatening Infectious Diseases in Patients with Acute Hepatic Porphyria.急性肝卟啉病患者急慢性危及生命的传染病治疗实用建议
Metabolites. 2025 Feb 5;15(2):99. doi: 10.3390/metabo15020099.
8
An easily overlooked disease in the early stages: acute intermittent porphyria.一种在早期容易被忽视的疾病:急性间歇性卟啉病。
BMC Neurol. 2025 Feb 13;25(1):61. doi: 10.1186/s12883-025-04064-0.
9
Blood-CSF barrier clearance of ABC transporter substrates is suppressed by interleukin-6 in lupus choroid plexus spheroids.狼疮脉络丛球体中白细胞介素-6抑制ABC转运蛋白底物的血脑脊液屏障清除。
Fluids Barriers CNS. 2025 Feb 11;22(1):15. doi: 10.1186/s12987-025-00628-x.
10
Porphyric encephalopathy in a 15-year-old girl: A case report.一名15岁女孩的卟啉性脑病:病例报告
SAGE Open Med Case Rep. 2025 Jan 28;13:2050313X241298532. doi: 10.1177/2050313X241298532. eCollection 2025.
卟啉病相关性后部可逆性脑病综合征与中枢神经系统功能障碍。
Mol Genet Metab. 2019 Nov;128(3):242-253. doi: 10.1016/j.ymgme.2019.10.011. Epub 2019 Nov 1.
4
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.探索:一项针对有反复发作史的急性肝性血卟啉症患者的前瞻性、多中心、自然病史研究。
Hepatology. 2020 May;71(5):1546-1558. doi: 10.1002/hep.30936. Epub 2019 Nov 7.
5
Clinical Guide and Update on Porphyrias.临床指南和卟啉病更新。
Gastroenterology. 2019 Aug;157(2):365-381.e4. doi: 10.1053/j.gastro.2019.04.050. Epub 2019 May 11.
6
Feasibility of cellular bioenergetics as a biomarker in porphyria patients.细胞生物能量学作为卟啉症患者生物标志物的可行性。
Mol Genet Metab Rep. 2019 Jan 29;19:100451. doi: 10.1016/j.ymgmr.2019.100451. eCollection 2019 Jun.
7
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.急性间歇性卟啉症的 RNA 干扰疗法的 1 期临床试验。
N Engl J Med. 2019 Feb 7;380(6):549-558. doi: 10.1056/NEJMoa1807838.
8
Nonconvulsive status epilepticus secondary to acute porphyria crisis.急性卟啉病危象继发非惊厥性癫痫持续状态
Epilepsy Behav Case Rep. 2018 Nov 28;11:43-46. doi: 10.1016/j.ebcr.2018.11.002. eCollection 2019.
9
Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome: Two case reports and a literature review.以癫痫发作和后部可逆性脑病综合征为表现的急性间歇性卟啉病:两例报告及文献综述
Medicine (Baltimore). 2018 Sep;97(36):e11665. doi: 10.1097/MD.0000000000011665.
10
A case of hereditary coproporphyria with posterior reversible encephalopathy and novel coproporphyrinogen oxidase gene mutation c.863T>G (p.Leu288Trp).一例伴有后部可逆性脑病的遗传性粪卟啉病及新型粪卟啉原氧化酶基因突变c.863T>G(p.Leu288Trp)
Ann Clin Biochem. 2018 Sep;55(5):616-619. doi: 10.1177/0004563218774597. Epub 2018 Apr 27.